ACE and breast neoplasm: Our results together with the relationship between bleomycin and ACE expression described in the preceding paragraph suggest that patients with basal-like breast tumors would be more sensitive to bleomycin; and if treated with bleomycin, would have lower ACE expression, thus, less fibrosis, than similarly treated patients with the luminal subtypes and Her2-positive subtype.